146 related articles for article (PubMed ID: 22571261)
1. Non-inclusion complexes between riboflavin and cyclodextrins.
de Jesus MB; Fraceto LF; Martini MF; Pickholz M; Ferreira CV; de Paula E
J Pharm Pharmacol; 2012 Jun; 64(6):832-42. PubMed ID: 22571261
[TBL] [Abstract][Full Text] [Related]
2. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
4. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
5. Lyophilization monophase solution technique for improvement of the physicochemical properties of an anticancer drug, flutamide.
Elgindy N; Elkhodairy K; Molokhia A; Elzoghby A
Eur J Pharm Biopharm; 2010 Feb; 74(2):397-405. PubMed ID: 19944160
[TBL] [Abstract][Full Text] [Related]
6. Melarsoprol-cyclodextrins inclusion complexes.
Gibaud S; Zirar SB; Mutzenhardt P; Fries I; Astier A
Int J Pharm; 2005 Dec; 306(1-2):107-21. PubMed ID: 16253447
[TBL] [Abstract][Full Text] [Related]
7. Gefitinib-cyclodextrin inclusion complexes: physico-chemical characterization and dissolution studies.
Phillip Lee YH; Sathigari S; Jean Lin YJ; Ravis WR; Chadha G; Parsons DL; Rangari VK; Wright N; Babu RJ
Drug Dev Ind Pharm; 2009 Sep; 35(9):1113-20. PubMed ID: 19640249
[TBL] [Abstract][Full Text] [Related]
8. Analysis of triclosan inclusion complexes with β-cyclodextrin and its water-soluble polymeric derivative.
Jug M; Kosalec I; Maestrelli F; Mura P
J Pharm Biomed Anal; 2011 Apr; 54(5):1030-9. PubMed ID: 21215544
[TBL] [Abstract][Full Text] [Related]
9. Spectroscopic characterization of the inclusion complexes of luteolin with native and derivatized beta-cyclodextrin.
Jullian C; Cifuentes C; Alfaro M; Miranda S; Barriga G; Olea-Azar C
Bioorg Med Chem; 2010 Jul; 18(14):5025-31. PubMed ID: 20576438
[TBL] [Abstract][Full Text] [Related]
10. In vitro drug release of natamycin from β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin-functionalized contact lens materials.
Phan CM; Subbaraman LN; Jones L
J Biomater Sci Polym Ed; 2014; 25(17):1907-19. PubMed ID: 25226305
[TBL] [Abstract][Full Text] [Related]
11. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
12. Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/cyclodextrin complexes.
Messner M; Kurkov SV; Brewster ME; Jansook P; Loftsson T
Int J Pharm; 2011 Apr; 407(1-2):174-83. PubMed ID: 21237259
[TBL] [Abstract][Full Text] [Related]
13. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium.
Ungaro F; Giovino C; Catanzano O; Miro A; Mele A; Quaglia F; La Rotonda MI
Int J Pharm; 2011 Feb; 404(1-2):49-56. PubMed ID: 21056648
[TBL] [Abstract][Full Text] [Related]
14. Molecular dynamics simulations of UC781-cyclodextrins inclusion complexes in aqueous solution.
Boonyarattanakalin K; Wolschann P; Toochinda P; Lawtrakul L
Eur J Pharm Sci; 2012 Nov; 47(4):752-8. PubMed ID: 22922099
[TBL] [Abstract][Full Text] [Related]
15. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complex and nanoclusters of cyclodextrin to increase the solubility and efficacy of albendazole.
Pacheco PA; Rodrigues LNC; Ferreira JFS; Gomes ACP; Veríssimo CJ; Louvandini H; Costa RLD; Katiki LM
Parasitol Res; 2018 Mar; 117(3):705-712. PubMed ID: 29327323
[TBL] [Abstract][Full Text] [Related]
17. Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.
Fernandes CM; Carvalho RA; Pereira da Costa S; Veiga FJ
Eur J Pharm Sci; 2003 Apr; 18(5):285-96. PubMed ID: 12694880
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the 2:1 molecular recognition and inclusion behaviour between beta- and gamma-cyclodextrins and cinchonine.
Wen X; Liu Z; Zhu T; Zhu M; Jiang K; Huang Q
Bioorg Chem; 2004 Aug; 32(4):223-33. PubMed ID: 15210337
[TBL] [Abstract][Full Text] [Related]
19. Formulation of rifampicin-cyclodextrin complexes for lung nebulization.
Tewes F; Brillault J; Couet W; Olivier JC
J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353
[TBL] [Abstract][Full Text] [Related]
20. Preparation, characterisation and antitumour activity of β-, γ- and HP-β-cyclodextrin inclusion complexes of oxaliplatin.
Zhang D; Zhang J; Jiang K; Li K; Cong Y; Pu S; Jin Y; Lin J
Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():501-8. PubMed ID: 26254603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
